Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000597551 | SCV000708976 | uncertain significance | not provided | 2018-06-21 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000765479 | SCV000896770 | uncertain significance | Insulin-resistant diabetes mellitus AND acanthosis nigricans; Hyperinsulinism due to INSR deficiency; Leprechaunism syndrome; Rabson-Mendenhall syndrome | 2021-11-30 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV003884654 | SCV004698154 | uncertain risk allele | Hyperinsulinism due to INSR deficiency | criteria provided, single submitter | research | Potent mutations in INSR gene can lead to insulin resistance, which presents as impaired glucose tolerance, early onset type 2 diabetes, post prandial hyperglycemia and increased insulin requirement in type 1 diabetes. These mutations in INSR gene can also predispose to coronary artery disease, metabolic syndrome, polycystic ovarian disease and non alcoholic fatty liver disease.However, the role of this particular variant rs777565396 with early onset diabetes mellitus is yet to be ascertained. |